ASCO 2019 and the future of oncology
iStock-1019106928-ASCO

ASCO 2019 round-up

With the American Society of Clinical Oncology (ASCO) conference over for another year, Richard Staines presents a round-up of the most significant developments at this year’s event.

Views & Analysis
Optimising market access for biosimilars

Optimising market access for biosimilars

We speak to Sandoz’s global head of biopharmaceuticals, Stefan Hendriks, about the remaining challenges in market access for biosimilars and what the future could hold for this still-bu

Views & Analysis
Reimagining commercialisation with AI

Reimagining commercialisation with AI

We speak to Indegene’s Gaurav Kapoor to find out how he thinks pharma’s sales and marketing model needs to change and why AI is the solution.

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Market Access
Solution Spotlight: Acumetis Model Builder
Sponsored

Solution Spotlight: Acumetis Model Builder

Acumetis Model Builder is a web-based platform that generates complete, formula-linked Excel cost-effectiveness and budget impact models in minutes.

Newsletters and Deep Dive
digital magazine

Oncology

Patients

R&D